AGM/EGMJun 4, 2026, 06:07 AM
AVITA Medical Stockholders Approve Director Fee Pool Increase to $900K
AI Summary
AVITA Medical, Inc. held its 2026 Annual Meeting of Stockholders, where all seven directors were re-elected to the Board of Directors. Stockholders also ratified Grant Thornton LLP as the independent registered public accounting firm for 2026. Key approvals included an increase in the aggregate annual cash fee pool for non-executive directors from $750,000 to $900,000, and the issuance of annual and initial equity awards (restricted stock units and stock options) to non-executive directors.
Key Highlights
- All seven directors named in the proxy statement were elected to the Board.
- Grant Thornton LLP was ratified as the independent auditor for the year ending December 31, 2026.
- Non-executive director annual cash fee pool increased from $750,000 to $900,000.
- Annual grants of 22,214 restricted stock units and 16,133 stock options approved for each non-executive director.
- Initial grant of 26,250 restricted stock units and 19,063 stock options approved for Dr. Michael Tarnoff.
- Initial grant of 40,547 restricted stock units and 29,446 stock options approved for Joseph Woody.
Price Impact
More from RCEL